Related Experiment Video
Updated: Feb 1, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Massive Splenic Infarction in a Child With Sickle Cell Disease on Chronic Transfusion Therapy
Maria A Pereda1, Jaya Isaac2, Yaoping Zhang1
1Departments of Pediatrics.
Insights
Massive splenic infarction (MSI) is a rare complication in sickle cell disease. Elective splenectomy may be considered for patients with hypersplenism, despite associated risks.
Area of Science:
- Hematology
- Pediatric Medicine
- Vascular Complications
Background:
- Sickle cell disease (SCD) typically leads to splenic atrophy in early childhood.
- Massive splenic infarction (MSI) is an uncommon complication in SCD patients.
- Chronic transfusion therapy can paradoxically lead to hypersplenism in SCD.
Observation:
- A 12-year-old boy with homozygous sickle cell anemia (Hb SS) developed MSI.
- The patient's MSI occurred secondary to hypersplenism induced by chronic transfusion therapy.
- This case highlights a rare presentation of splenic complications in SCD.
Findings:
- MSI occurred in a pediatric patient with Hb SS despite expected splenic atrophy.
- Hypersplenism, a consequence of chronic transfusion, was identified as the likely cause.
- The case underscores the complex splenic dynamics in SCD management.
Implications:
- Consider MSI in SCD patients presenting with abdominal pain, especially those on chronic transfusions.
- Elective splenectomy might be a viable option for managing hypersplenism and preventing MSI.
- Careful risk-benefit analysis is crucial when considering splenectomy due to potential complications.
Abstract:
Massive splenic infarction (MSI) is a rare complication of sickle cell disease, as the spleen generally atrophies within the first few years of life. We report a case of MSI in a 12-year-old boy with homozygous sickle cell anemia (Hb SS) whose chronic transfusion therapy resulted in hypersplenism. The occurrence of a complicated MSI in our patient should perhaps further encourage elective splenectomy in such patients, despite known potential perioperative complications and postsplenectomy risks of infection and thrombosis.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-I: Introduction

